Molecular Imaging 2017

Patient with suspected cancer

MRI: Detection

Focal lesion

No focal lesion

Targeted biopsy

Systematic biopsy

Consider

Low risk

Intermediate risk

High risk

cStage ≥T3a or PSA ng/mL >20 or Gleason 8-10

cStage T1-2a & PSA ng/mL <10 & Gleason ≤6

cStage T2b-c or PSA ng/mL 10-20 or Gleason 7